ABL Diagnostics (XPAR:ABLD) Additional Paid-In Capital : €3.39 Mil(As of Jun. 2023)

View and export this data going back to 1989. Start your Free Trial

What is ABL Diagnostics Additional Paid-In Capital?

ABL Diagnostics's quarterly additional paid-in capital increased from Jun. 2022 (€0.21 Mil) to Dec. 2022 (€3.39 Mil) but then stayed the same from Dec. 2022 (€3.39 Mil) to Jun. 2023 (€3.39 Mil).

ABL Diagnostics's annual additional paid-in capital stayed the same from Dec. 2020 (€0.21 Mil) to Dec. 2021 (€0.21 Mil) but then increased from Dec. 2021 (€0.21 Mil) to Dec. 2022 (€3.39 Mil).

ABL Diagnostics Additional Paid-In Capital Historical Data

The historical data trend for ABL Diagnostics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Diagnostics Additional Paid-In Capital Chart

ABL Diagnostics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Additional Paid-In Capital

Get a 7-Day Free Trial

0.21

3.39

ABL Diagnostics Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Additional Paid-In Capital	Get a 7-Day Free Trial															0.21	0.21	0.21	3.39	3.39

ABL Diagnostics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

ABL Diagnostics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of ABL Diagnostics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

ABL Diagnostics (XPAR:ABLD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » ABL Diagnostics (XPAR:ABLD) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

72c, rue de, WOIPPY, Thionville, FRA, 57140

Website

https://www.abldiagnostics.com

ABL Diagnostics is a diagnostic and medical software company. The group has focused on the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. It also develops, manufactures, and markets kits for clinical specimen collection.

ABL Diagnostics (XPAR:ABLD) Headlines

No Headlines